Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Axillary dissection in clinically node negative breast cancer patients undergoing breast conserving surgery

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.12.18
Views: 567
Rating:

Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA

Dr Andrea Barrio speaks to ecancer at SABCS 2018 about the study into axillary dissection in clinically node negative breast cancer patients undergoing breast conserving surgery.

She explains that the primary endpoint was to look at nodal recurrence and they demonstrated no isolated axillary failures.

Dr Barrio believes that the implications of this study are that they have demonstrated low rates of nodal recurrence in patients with MECE meaning that these patients can be safely treated without axillary lymph node dissection.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation